Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: A 3-year longitudinal multicenter study in a non-endemic area

Category Primary study
JournalOrphanet Journal of Rare Diseases
Year 2015
This article has no abstract
Epistemonikos ID: da7d5fba30141eb5df077a65c70b8d7cc2203df7
First added on: Feb 08, 2025